Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial
Year: 2015
Type: article
Study design: Clinical Trial
Source: The Lancet
Institutions: Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Bellvitge University Hospital, Hospital de Sant Pau, Hospital Clínico San Carlos, Hospital General Universitario de Alicante Doctor Balmis, University of Ferrara, Azienda Ospedaliera Bolognini Seriate, Amphia Ziekenhuis, Hospital Universitario Son Espases, Cardialysis (Netherlands), University Hospital of Bern, Erasmus MC, Imperial College London
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: ST-elevation myocardial infarction, everolimus-eluting stent, bare-metal stents, drug-eluting stents, all-cause mortality, myocardial infarction, revascularization, long-term clinical outcomes, biodegradable stents, bioresorbable scaffolds, coronary stenting, secondary prevention of myocardial infarction
Open Access status: bronze
Funder: Abbott Vascular
OpenAlex ID: W1846993152
